|
1
|
Zhao L, Zhang J, Tan H, Wang W, Liu Y,
Song R and Wang L: Gene function analysis in osteosarcoma based on
microarray gene expression profiling. Int J Clin Exp Med.
8:10401–10410. 2015.PubMed/NCBI
|
|
2
|
Isakoff MS, Bielack SS, Meltzer P and
Gorlick RL: Osteosarcoma: Current treatment and a collaborative
pathway to success. J Clin Oncol. 33:3029–3035. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim JS, Chung CY, Park HC, Myung DS, Cho
SB, Lee WS, Min JJ and Joo YE: Synchronous quadruple primary tumors
of thyroid, breast, pancreas and stomach: A case report. Anticancer
Res. 33:2135–2138. 2013.PubMed/NCBI
|
|
4
|
Aung L, Gorlick RG, Shi W, Thaler H,
Shorter NA, Healey JH, Huvos AG and Meyers PA: Second malignant
neoplasms in long-term survivors of osteosarcoma: Memorial
sloan-kettering cancer center experience. Cancer. 95:1728–1734.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pratt CB, Meyer WH, Luo X, Cain AM, Kaste
SC, Pappo AS, Rao BN, Fleming ID and Jenkins JJ III: Second
malignant neoplasms occuring in survivors of osteosarcoma. Cancer.
80:960–965. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim SH, Shin KH, Seok SO, Cho YJ, Noh JK,
Suh JS and Yang WI: Secondary malignant neoplasms after
osteosarcoma: Early onset and cumulative alkylating agent dose
dependency. Ann Surg Oncol. 22:859–865. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee JS, DuBois SG, Boscardin WJ, Wustrack
RL and Goldsby RE: Secondary malignant neoplasms among children,
adolescents and young adults with osteosarcoma. Cancer.
120:3987–3993. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Quartuccio N, Treglia G, Salsano M,
Mattoli MV, Muoio B, Piccardo A, Lopci E and Cistaro A: The role of
Fluorine-18-Fluorodeoxyglucose positron emission tomography in
staging and restaging of patients with osteosarcoma. Radiol Oncol.
47:97–102. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Costelloe CM, Chuang HH and Daw NC: PET/CT
of Osteosarcoma and ewing sarcoma. Semin Roentgenol. 52:255–268.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Harrison DJ, Parisi MT and Shulkin BL: The
Role of 18F-FDG-PET/CT in pediatric sarcoma. Semin Nucl Med.
47:229–241. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Byun BH, Kong CB, Lim I, Choi CW, Song WS,
Cho WH, Jeon DG, Koh JS, Lee SY and Lim SM: Combination of 18F-FDG
PET/CT and diffusion-weighted MR imaging as a predictor of
histologic response to neoadjuvant chemotherapy: Preliminary
results in osteosarcoma. J Nucl Med. 54:1053–1059. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Byun BH, Kong CB, Lim I, Kim BI, Choi CW,
Song WS, Cho WH, Jeon DG, Koh JS and Lim SM: Early response
monitoring to neoadjuvant chemotherapy in osteosarcoma using
sequential 18F-FDG PET/CT and MRI. Eur J Nucl Med Mol Imaging.
41:1553–1562. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hurley C, McCarville MB, Shulkin BL, Mao
S, Wu J, Navid F, Daw NC, Pappo AS and Bishop MW: Comparison of
(18) F-FDG-PET-CT and bone scintigraphy for evaluation of osseous
metastases in newly diagnosed and recurrent osteosarcoma. Pediatr
Blood Cancer. 63:1381–1386. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Angelini A, Ceci F, Castellucci P,
Graziani T, Polverari G, Trovarelli G, Palmerini E, Ferrari S,
Fanti S and Ruggieri P: The role of 18F-FDG PET/CT in the detection
of osteosarcoma recurrence. Eur J Nucl Med Mol Imaging.
44:1712–1720. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rothermundt C, Seddon BM, Dileo P, Strauss
SJ, Coleman J, Briggs TW, Haile SR and Whelan JS: Follow-up
practices for high-grade extremity Osteosarcoma. BMC Cancer.
16:3012016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Paioli A, Rocca M, Cevolani L, Rimondi E,
Vanel D, Palmerini E, Cesari M, Longhi A, Eraldo AM, Marchesi E, et
al: Osteosarcoma follow-up: chest X-ray or computed tomography?
Clin Sarcoma Res. 7:32017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Quartuccio N, Fox J, Kuk D, Wexler LH,
Baldari S, Cistaro A and Schöder H: Pediatric bone sarcoma:
Diagnostic performance of 18F-FDG PET/CT versus conventional
imaging for initial staging and follow-up. AJR Am J Roentgenol.
204:153–160. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lazar A and Mertens F: Parosteal
osteosarcomaWHO classification of tumors of soft tissue and bone.
Fletcher CDM, Bridge JA, Hogendoorn PCW and Mertens F: IARC Press;
Lyon: pp. 292–293. 2013
|
|
19
|
Warren S and Gates O: Multiple primary
malignant tumors: a survey of the literature and a statistical
study. Am J Cancer. 16:1358–1414. 1932.
|
|
20
|
Nagarajan R, Kamruzzaman A, Ness KK,
Marchese VG, Sklar C, Mertens A, Yasui Y, Robison LL and Marina N:
Twenty years of follow-up of survivors of childhood osteosarcoma: A
report from the Childhood Cancer Survivor Study. Cancer.
117:625–634. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bacci G, Ferrari C, Longhi A, Ferrari S,
Forni C, Bacchini P, Palmerini E, Briccoli A, Pignotti E,
Balladelli A, et al: Second malignant neoplasm in patients with
osteosarcoma of the extremities treated with adjuvant and
neoadjuvant chemotherapy. J Pediatr Hematol Oncol. 28:774–780.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Almangush A, Coletta RD, Bello IO, Bitu C,
Keski-Säntti H, Mäkinen LK, Kauppila JH, Pukkila M, Hagström J,
Laranne J, et al: A simple novel prognostic model for early stage
oral tongue cancer. Int J Oral Maxillofac Surg. 44:143–150. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bacci G, Ferrari S, Bertoni F, Ruggieri P,
Picci P, Longhi A, Casadei R, Fabbri N, Forni C, Versari M and
Campanacci M: Long-term outcome for patients with nonmetastatic
osteosarcoma of the extremity treated at the istituto ortopedico
rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2
protocol: An updated report. J Clin Oncol. 18:4016–4027. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yonemoto T, Tatezaki S, Ishii T, Hagiwara
Y and Inoue M: Multiple primary cancers in patients with
osteosarcoma: Influence of anticancer drugs and genetic factors. Am
J Clin Oncol. 27:220–224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hauben EI, Arends J, Vandenbroucke JP, van
Asperen CJ, Van Marck E and Hogendoorn PC: Multiple primary
malignancies in osteosarcoma patients. Incidence and predictive
value of osteosarcoma subtype for cancer syndromes related with
osteosarcoma. Eur J Hum Genet. 11:611–618. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu P, Holman CD, Jin J and Zhang M:
Alcohol consumption and risk of myelodysplastic syndromes: A
case-control study. Cancer Causes Control. 27:209–216. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tong H, Hu C, Yin X, Yu M, Yang J and Jin
J: A meta-analysis of the relationship between cigarette smoking
and incidence of myelodysplastic syndromes. PLoS One. 8:e675372013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Johnson CM, Wei C, Ensor JE, Smolenski DJ,
Amos CI, Levin B and Berry DA: Meta-analyses of colorectal cancer
risk factors. Cancer Causes Control. 24:1207–1222. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Parajuli R, Bjerkaas E, Tverdal A, Le
Marchand L, Weiderpass E and Gram IT: Cigarette smoking and
colorectal cancer mortality among 602,242 Norwegian males and
females. Clin Epidemiol. 7:137–145. 2014.
|
|
30
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kubota M, Sawada M, Watanabe K, Koishi S,
Kataoka A, Usami I, Lin YW, Okuda A, Akiyama Y and Furusho K:
Myelodysplastic syndrome presenting as third malignancy after
non-Hodgkin's lymphoma and osteosarcoma. Ann Hematol. 74:95–97.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kimura K, Shinmura K, Hasegawa T, Beppu Y,
Yokoyama R and Yokota J: Germline p53 mutation in a patient with
multiple primary cancers. Jpn J Clin Oncol. 31:349–351. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kousaka J, Fujii K, Yorozuya K, Mouri Y,
Yoshida M, Nakano S, Fukutomi T, Takahashi E and Yokoi T: A case of
quadruple primary malignancies including breast, tongue and thyroid
cancers and osteosarcoma in a young female without karyotype
abnormality. Breast Cancer. 21:500–503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hauben EI, Bielack S, Grimer R, Jundt G,
Reichardt P, Sydes M, Taminiau AH and Hogendoorn PC:
Clinico-histologic parameters of osteosarcoma patients with late
relapse. Eur J Cancer. 42:460–466. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jaffe N, Pearson P, Yasko AW, Lin P,
Herzog C and Raymond K: Single and multiple metachronous
osteosarcoma tumors after therapy. Cancer. 98:2457–2466. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Currall VA and Dixon JH: Synchronous
multifocal osteosarcoma: Case report and Literature review.
Sarcoma. 2006:539012006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Anderson ME: Update on survival in
osteosarcoma. Orthop Clin North Am. 47:283–292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
van den Berg H, Schreuder WH and de Lange
J: Osteosarcoma: A comparison of jaw versus nonjaw localizations
and review of the literature. Sarcoma. 2013:3161232013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kumar VS, Barwar N and Khan SA: Surface
osteosarcomas: Diagnosis, treatment and outcome. Indian J Orthop.
48:255–261. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bertoni F, Bacchini P, Staals EL and
Davidovitz P: Dedifferentiated parosteal osteosarcoma: The
experience of the Rizzoli Institute. Cancer. 103:2373–2382. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bertoni F, Dallera P, Bacchini P,
Marchetti C and Campobassi A: The Istituto Rizzoli-Beretta
experience with osteosarcoma of the jaw. Cancer. 68:1555–1563.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sawair FA, Cheng J, Hao N, Maruyama S,
Hoshina H, Takagi R, Koyama J, Hayashi T and Saku T: Periosteal
osteosarcoma of the jaw bones: a clinicopathologic review. Oral Med
Pathol. 12:3–10. 2007. View Article : Google Scholar
|
|
43
|
Brenner W, Bohuslavizki KH and Eary JF:
PET imaging of osteosarcoma. J Nucl Med. 44:930–942.
2003.PubMed/NCBI
|
|
44
|
Moertel CG, Dockerty MB and Baggenstoss
AH: Multiple primary malignant neoplasms. I. Introduction and
presentation of data. Cancer. 14:221–230. 1961. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kim MS, Sim YS, Lee SY and Jeon DG: Occult
thyroid carcinoma detected by FDG-PET scan in elderly osteosarcoma
patients: Report of two cases. Ann Nucl Med. 21:529–532. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gavane S, Price AP, Magnan H, Mahajan S
and Pandit-Taskar N: Multifocal osteosarcoma: Unusual presentation
and imaging findings. Clin Nucl Med. 42:e202–e206. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kneisl JS, Patt JC, Johnson JC and Zuger
JH: Is PET useful in detecting occult nonpulmonary metastases in
pediatric bone sarcomas? Clin Orthop Relat Res. 450:101–104. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jain KS, Sikora AG, Baxi SS and Morris LG:
Synchronous cancers in patients with head and neck cancer: Risks in
the era of human papillomavirus-associated oropharyngeal cancer.
Cancer. 119:1832–1837. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Coyte A, Morrison DS and McLoone P: Second
primary cancer risk-the impact of applying different definitions of
multiple primaries: Results from a retrospective population-based
cancer registry study. BMC Cancer. 14:2722014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yildiz FR, Avci A, Dereci O, Erol B,
Celasun B and Gunhan O: Gnathic osteosarcomas, experience of four
institutions from Turkey. Int J Clin Exp Pathol. 7:2800–2808.
2014.PubMed/NCBI
|
|
51
|
Kahi CJ, Imperiale TF, Juliar BE and Rex
DK: Effect of screening colonoscopy on colorectal cancer incidence
and mortality. Clin Gastroenterol Hepatol. 7:770–775. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang HY, Ding HJ, Chen JH, Chao CH, Lu YY,
Lin WY and Kao CH: Meta-analysis of the diagnostic performance of
[18F]FDG-PET and PET/CT in renal cell carcinoma. Cancer Imaging.
12:464–474. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chang KJ, Kong CB, Cho WH, Jeon DG, Lee
SY, Lim I and Lim SM: Usefulness of increased 18F-FDG uptake for
detecting local recurrence in patients with extremity osteosarcoma
treated with surgical resection and endoprosthetic replacement.
Skeletal Radiol. 44:529–537. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Franzius C, Daldrup-Link HE, Wagner-Bohn
A, Sciuk J, Heindel WL, Jürgens H and Schober O: FDG-PET for
detection of recurrences from malignant primary bone tumors:
Comparison with conventional imaging. Ann Oncol. 13:157–160. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Piperkova E, Mikhaeil M, Mousavi A, Libes
R, Viejo-Rullan F, Lin H, Rosen G and Abdel-Dayem H: Impact of PET
and CT in PET/CT studies for staging and evaluating treatment
response in bone and soft tissue sarcomas. Clin Nucl Med.
34:146–150. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Fuglø HM, Jørgensen SM, Loft A, Hovgaard D
and Petersen MM: The diagnostic and prognostic value of 18F-FDG
PET/CT in the initial assessment of high-grade bone and soft tissue
sarcoma. A retrospective study of 89 patients. Eur J Nucl Med Mol
Imaging. 39:1416–1424. 2012. View Article : Google Scholar : PubMed/NCBI
|
